PEB:ASX
Pacific Edge Ltd
A$ ०.१९
०.००%
(०.००) 1D
अक्टोबर २७, १६:००:०० GMT+११ · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PEB...
Open
A$ ०.१९
High
A$ ०.१९
Low
A$ ०.१९
Mkt. cap
२८.५६ करोड
Avg. vol.
१०.८७ हजार
Volume
५.२३ हजार
52-wk high
A$ ०.२६
52-wk low
A$ ०.१२
No. of employees
११४
Open
A$ ०.१९
High
A$ ०.१९
Low
A$ ०.१९
Mkt. cap
२८.५६ करोड
Avg. vol.
१०.८७ हजार
Volume
५.२३ हजार
52-wk high
A$ ०.२६
52-wk low
A$ ०.१२
No. of employees
११४
News stories
From web sources and news partners
The National Law Review
·
५ मिनेट पहिले
iQSTEL (NASDAQ: IQST) Executives Discuss Path to $1 Billion Reven
11Alive.com
·
१३ मिनेट पहिले
Wall Street wobbles on AI spending
The Defiant
·
१० मिनेट पहिले
Janus Henderson Announces Tokenized Nasdaq-100 Fund on Stellar
The Motley Fool
·
२४ मिनेट पहिले
Up 16% This Year, How Long Can Procter & Gamble Continue Outperforming the S&P 500?
Profile
Pacific Edge Limited, based in New Zealand, focuses on cancer diagnostics with a suite of bladder cancer diagnostic tools using genetic biomarkers. The company operates with a head office in Dunedin, New Zealand, and also has an office in Hershey, USA. It is listed on the Australian ASX and the New Zealand NZX main board stock exchange. Wikipedia
About Pacific Edge Ltd